ICONIQ Growth completed the $150m investment in Enfusion.

ICONIQ Growth, a tech-focused direct investment effort that is affiliated with ICONIQ Capital, completed the $150m investment in Enfusion, a global company in investment management technology solutions and services. “Our job is to empower and support investment managers wherever they are in their operational journey. As we continue to better position ourselves to meet the needs of our clients, we have worked to remove the silos traditionally associated with portfolio management, order management, trading, operations, accounting, IR, and many other services. ICONIQ shares this vision and we are humbled to have their support in this journey, advancing our commitment to help our clients transform their businesses and grow,” Thomas Kim, Enfusion CEO.